| Rank |
Title |
Journal |
Year |
PubWeight™‹?› |
|
1
|
An illustrated consensus on the classification of pancreatic intraepithelial neoplasia and intraductal papillary mucinous neoplasms.
|
Am J Surg Pathol
|
2004
|
4.74
|
|
2
|
Classification of types of intraductal papillary-mucinous neoplasm of the pancreas: a consensus study.
|
Virchows Arch
|
2005
|
2.76
|
|
3
|
Pathologic features of mucin-producing bile duct tumors: two histopathologic categories as counterparts of pancreatic intraductal papillary-mucinous neoplasms.
|
Am J Surg Pathol
|
2004
|
1.59
|
|
4
|
New classification of pancreatic intraductal papillary-mucinous tumour by mucin expression: its relationship with potential for malignancy.
|
J Pathol
|
2002
|
1.54
|
|
5
|
MUC4 is a novel prognostic factor of extrahepatic bile duct carcinoma.
|
Clin Cancer Res
|
2006
|
1.46
|
|
6
|
MUC4 is a novel prognostic factor of intrahepatic cholangiocarcinoma-mass forming type.
|
Hepatology
|
2004
|
1.43
|
|
7
|
RNA interference suppression of MUC1 reduces the growth rate and metastatic phenotype of human pancreatic cancer cells.
|
Clin Cancer Res
|
2006
|
1.40
|
|
8
|
Prognostic relevance of morphological types of intraductal papillary mucinous neoplasms of the pancreas.
|
Gut
|
2010
|
1.35
|
|
9
|
Mucin expression profile in pancreatic cancer and the precursor lesions.
|
J Hepatobiliary Pancreat Surg
|
2007
|
1.23
|
|
10
|
A micropapillary pattern is predictive of a poor prognosis in lung adenocarcinoma, and reduced surfactant apoprotein A expression in the micropapillary pattern is an excellent indicator of a poor prognosis.
|
Mod Pathol
|
2007
|
1.22
|
|
11
|
MUC4 expression correlates with poor prognosis in small-sized lung adenocarcinoma.
|
Lung Cancer
|
2006
|
1.22
|
|
12
|
MUC1 expression is regulated by DNA methylation and histone H3 lysine 9 modification in cancer cells.
|
Cancer Res
|
2008
|
1.18
|
|
13
|
Terminal stage cardiac findings in patients with cardiac Fabry disease: an electrocardiographic, echocardiographic, and autopsy study.
|
J Cardiol
|
2008
|
1.16
|
|
14
|
MUC4 and MUC1 expression in adenocarcinoma of the stomach correlates with vessel invasion and lymph node metastasis: an immunohistochemical study of early gastric cancer.
|
PLoS One
|
2012
|
1.09
|
|
15
|
Molecular detection of FUS-CREB3L2 fusion transcripts in low-grade fibromyxoid sarcoma using formalin-fixed, paraffin-embedded tissue specimens.
|
Am J Surg Pathol
|
2006
|
1.08
|
|
16
|
Uterine lipoleiomyoma: a histopathological review of 17 cases.
|
Pathol Int
|
2004
|
1.07
|
|
17
|
Mycolactone is responsible for the painlessness of Mycobacterium ulcerans infection (buruli ulcer) in a murine study.
|
Infect Immun
|
2008
|
1.06
|
|
18
|
Increased expression of MUC1 in advanced pancreatic cancer.
|
J Gastroenterol
|
2003
|
1.06
|
|
19
|
Nerve damage in Mycobacterium ulcerans-infected mice: probable cause of painlessness in buruli ulcer.
|
Am J Pathol
|
2006
|
1.02
|
|
20
|
MUC2 expression is regulated by histone H3 modification and DNA methylation in pancreatic cancer.
|
Int J Cancer
|
2006
|
0.99
|
|
21
|
Pathobiological implications of MUC16/CA125 expression in intrahepatic cholangiocarcinoma-mass forming type.
|
Pathobiology
|
2012
|
0.98
|
|
22
|
Expression of MUC1 and MUC2 mucins in extrahepatic bile duct carcinomas: its relationship with tumor progression and prognosis.
|
Pathol Int
|
2002
|
0.97
|
|
23
|
Polymorphisms of the CYP1B1 gene as risk factors for human renal cell cancer.
|
Clin Cancer Res
|
2004
|
0.94
|
|
24
|
Two autopsy cases of severe fever with thrombocytopenia syndrome (SFTS) in Japan: a pathognomonic histological feature and unique complication of SFTS.
|
Pathol Int
|
2014
|
0.94
|
|
25
|
MUC4: a novel prognostic factor of oral squamous cell carcinoma.
|
Int J Cancer
|
2011
|
0.92
|
|
26
|
The application of methylation specific electrophoresis (MSE) to DNA methylation analysis of the 5' CpG island of mucin in cancer cells.
|
BMC Cancer
|
2012
|
0.90
|
|
27
|
Aberrant DNA methylation of tumor-related genes in oral rinse: a noninvasive method for detection of oral squamous cell carcinoma.
|
Cancer
|
2012
|
0.89
|
|
28
|
Immunohistochemical study of mucin expression in periampullary adenomyoma.
|
J Hepatobiliary Pancreat Sci
|
2009
|
0.89
|
|
29
|
DNA methylation and histone H3-K9 modifications contribute to MUC17 expression.
|
Glycobiology
|
2010
|
0.89
|
|
30
|
Epigenetic regulation of mucin genes in human cancers.
|
Clin Epigenetics
|
2011
|
0.89
|
|
31
|
Promoter hypomethylation contributes to the expression of MUC3A in cancer cells.
|
Biochem Biophys Res Commun
|
2010
|
0.88
|
|
32
|
Expression of MUC4 mucin is observed mainly in the intestinal type of intraductal papillary mucinous neoplasm of the pancreas.
|
Pancreas
|
2013
|
0.86
|
|
33
|
Expression of MUC5AC, an early marker of pancreatobiliary cancer, is regulated by DNA methylation in the distal promoter region in cancer cells.
|
J Hepatobiliary Pancreat Sci
|
2010
|
0.85
|
|
34
|
Human papillomavirus infection in lung and esophageal cancers: analysis of 485 Asian cases.
|
J Med Virol
|
2011
|
0.85
|
|
35
|
CpG hypermethylation of promoter region and inactivation of E-cadherin gene in human bladder cancer.
|
Mol Carcinog
|
2002
|
0.84
|
|
36
|
Mapping of the methylation pattern of the MUC2 promoter in pancreatic cancer cell lines, using bisulfite genomic sequencing.
|
Cancer Lett
|
2005
|
0.84
|
|
37
|
E-cadherin and beta-catenin expression in Epstein-Barr virus-associated gastric carcinoma and their prognostic significance.
|
World J Gastroenterol
|
2007
|
0.83
|
|
38
|
Mucin expression in endoscopic ultrasound-guided fine-needle aspiration specimens is a useful prognostic factor in pancreatic ductal adenocarcinoma.
|
Pancreas
|
2015
|
0.83
|
|
39
|
DF3 epitope expression on MUC1 mucin is associated with tumor aggressiveness, subsequent lymph node metastasis, and poor prognosis in patients with oral squamous cell carcinoma.
|
Cancer
|
2012
|
0.83
|
|
40
|
Ectopic expression of a GlcNAc 6-O-sulfotransferase, GlcNAc6ST-2, in colonic mucinous adenocarcinoma.
|
Glycobiology
|
2002
|
0.82
|
|
41
|
Expression of mucin antigens (MUC1 and MUC16) as a prognostic factor for mucinous adenocarcinoma of the uterine cervix.
|
J Obstet Gynaecol Res
|
2010
|
0.82
|
|
42
|
Uterine cervical carcinomas associated with lobular endocervical glandular hyperplasia.
|
Histopathology
|
2011
|
0.82
|
|
43
|
The antimetastatic role of thrombomodulin expression in islet cell-derived tumors and its diagnostic value.
|
Clin Cancer Res
|
2004
|
0.82
|
|
44
|
Aberrant overexpression of membrane-associated mucin contributes to tumor progression in adult T-cell leukemia/lymphoma cells.
|
Leuk Lymphoma
|
2011
|
0.82
|
|
45
|
Aberrant expression of pyloric gland-type mucin in mucin-producing bile duct carcinomas: a clear difference between the core peptide and the carbohydrate moiety.
|
Pathol Int
|
2005
|
0.81
|
|
46
|
Epstein-Barr virus-associated enteritis with multiple ulcers after stem cell transplantation: first histologically confirmed case.
|
Pathol Int
|
2006
|
0.81
|
|
47
|
RBPJ is a novel target for rhabdomyosarcoma therapy.
|
PLoS One
|
2012
|
0.81
|
|
48
|
Expression of mucin core proteins in extramammary Paget's disease.
|
Pathol Int
|
2002
|
0.81
|
|
49
|
Bilobular calcifying fibrous pseudotumor in soleus muscle: a case report.
|
J Med Case Rep
|
2011
|
0.80
|
|
50
|
Down-regulation of Gal 3-O-sulfotransferase-2 (Gal3ST-2) expression in human colonic non-mucinous adenocarcinoma.
|
Jpn J Cancer Res
|
2002
|
0.80
|
|
51
|
GLI2 is a novel therapeutic target for metastasis of osteosarcoma.
|
Int J Cancer
|
2014
|
0.80
|
|
52
|
Distribution of a single nucleotide polymorphism on codon 211 of the androgen receptor gene and its correlation with human renal cell cancer in Japanese patients.
|
Biochem Biophys Res Commun
|
2004
|
0.79
|
|
53
|
MUC1 mucin expression in follicular dendritic cells and lymphoepithelial lesions of gastric mucosa-associated lymphoid tissue lymphoma.
|
Pathol Int
|
2002
|
0.79
|
|
54
|
Primary epidural hemangiopericytoma in the lumbar spine: a case report.
|
Spine (Phila Pa 1976)
|
2002
|
0.79
|
|
55
|
Ectopic expression of N-acetylglucosamine 6-O-sulfotransferase 2 in chemotherapy-resistant ovarian adenocarcinomas.
|
Glycoconj J
|
2006
|
0.79
|
|
56
|
Expression of MUC17 is regulated by HIF1α-mediated hypoxic responses and requires a methylation-free hypoxia responsible element in pancreatic cancer.
|
PLoS One
|
2012
|
0.78
|
|
57
|
Castleman's disease in the retroperitoneal space mimicking a paraspinal schwannoma: a case report.
|
World J Surg Oncol
|
2013
|
0.78
|
|
58
|
Loss of p16/CDKN2A protein in Epstein-Barr virus-associated gastric carcinoma.
|
Oncology
|
2004
|
0.78
|
|
59
|
[End-stage cardiac manifestations and autopsy findings in patients with cardiac fabry disease].
|
J Cardiol
|
2004
|
0.78
|
|
60
|
Beta1,3-galactosyltransferases-4/5 are novel tumor markers for gynecological cancers.
|
Tumour Biol
|
2009
|
0.78
|
|
61
|
Comprehensive epigenetic analysis using oral rinse samples: a pilot study.
|
J Oral Maxillofac Surg
|
2011
|
0.77
|
|
62
|
Improved method for immunostaining of mucin separated by supported molecular matrix electrophoresis by optimizing the matrix composition and fixation procedure.
|
Electrophoresis
|
2011
|
0.77
|
|
63
|
Identification of mucins by using a method involving a combination of on-membrane chemical deglycosylation and immunostaining.
|
J Immunol Methods
|
2013
|
0.76
|
|
64
|
Mycobacterium leprae in neurons of the medulla oblongata and spinal cord in leprosy.
|
J Neuropathol Exp Neurol
|
2007
|
0.76
|
|
65
|
Cytochemistry of gastric parietal cells with high-pressure freezing followed by freeze-substitution.
|
J Electron Microsc (Tokyo)
|
2003
|
0.75
|
|
66
|
Combination of MUC1 and MUC4 expression predicts clinical outcome in patients with oral squamous cell carcinoma.
|
Int J Clin Oncol
|
2014
|
0.75
|
|
67
|
Assessment of tumor characteristics based on glycoform analysis of membrane-tethered MUC1.
|
Lab Invest
|
2017
|
0.75
|
|
68
|
Cured tuberculoid patients have a greater life expectancy than cured lepromatous patients in Japan.
|
Int J Lepr Other Mycobact Dis
|
2003
|
0.75
|
|
69
|
N-Acetylglucosamine 6-O-sulfotransferase-2 as a tumor marker for uterine cervical and corpus cancer.
|
Glycoconj J
|
2009
|
0.75
|